PSMID@ 50 Day 2 Plenary Sessions
1. Navigating the Maze of COVID-19 Diagnostics
Speaker: Raul V. Destura, MD, FPCP, PSMID Read more “PSMID@ 50 Day 2 Plenary Sessions”
1. Navigating the Maze of COVID-19 Diagnostics
Speaker: Raul V. Destura, MD, FPCP, PSMID Read more “PSMID@ 50 Day 2 Plenary Sessions” →
PANEL DISCUSSION: How are we faring as a country in our COVID19 Response?
1. Jonas del Rosario, MD (Patient)
2. Rabindra Abeyasinghe, MD, MSc, DTM&H (Public Health)
3. Nina Castillo-Carandang, MSc, PhD (Social Scientist)
4. Prof. Winnie Monsod, MA (Economist)
5. Maria Rosario S. Vergeire, MD, MPH, CESO IV (Government)
Moderators: Kathryn U. Roa, MD, FPCP, FPSMID & Bryan Albert Lim, MD, FPCP, FPSMID
Philippine College of Physicians
Philippine Society for Microbiology and Infectious Diseases
Healthcare Professionals Alliance Against Covid-19
HPAAC Unified Algorithms for COVID-19 Panel:
Lei Camiling Alfonso, MD
Antonio Dans, MD
Aileen Espina, MD
Mario Panaligan, MD
Maricar Limpin, MD
Karin Estepa-Garcia, MD
Ria Fajardo, MD
Pauline Convocar, MD
Moderator: Maaliddin Biruar, MD
Industry-Sponsored Lecture (Pfizer)
Defying the Odds: Importance of Vaccination During a Pandemic
Speaker: Rontgene M. Solante, MD, FPCP, FPSMID
Industry-Sponsored Lecture (Cathay)
Antiviral Options for COVID 19: What Works and What’s in the works?
Speakers:
Edsel Maurice T. Salvaña, MD, FPCP
Jubert P. Benedicto, MD, FPCP, FPCCP
Industry-Sponsored Lecture (Philcare Pharma)
High-Dose (HD) Tigecycline Therapy: A Potent carbapenem-sparing weapon against MDROs (CRE/A. bau)
Speaker: Adrian Joseph L. Buensalido, MD, FPCP, FPSMID
Moderator: Jemelyn U. Garcia, MD, FPC, FPSMID
Industry-Sponsored Lecture (Mylan)
Cardiac, Renal & Pulmonary complications in COVID-19 patients; expert experience in managing/recovery
Speakers:
Rontgene M. Solante, MD, FPCP, FPSMID
Aileen Wang, MD, FPCP, FPCCP
Industry-Sponsored Lecture (GSK)
COVID and AMR: Antibiotic Use During COVID-19 Pandemic and Implication for the Future
Speaker: Adrian Lijavetzki, MD
Industry-Sponsored Lecture (Roche)
Understanding COVID-19: Testing and Optimizing Testing Strategies
Speaker: Aw Tar Choon, MD
Patients undergoing regular hemodialysis are considered vulnerable and thus require specific guidelines in the context of COVID-19. The goal is to minimize the risk of transmission of SARS-CoV-2 in facilities that provide routine hemodialysis services to this specific group of immunocompromised individuals. This document will guide nephrologists, physicians and other healthcare professionals practicing in hemodialysis units as they attend to patients seeking hemodialysis services in their facilities. Recommendations in this rapid guidance are based on best available evidence and will be updated as new evidence becomes available.
You may download a copy of the PSN-PSMID-PHICS Interim Guidelines in the Prevention and Control of COVID19 Infection in Hemodialysis Facilities here.